Skip to main content
Toxicology Research logoLink to Toxicology Research
. 2021 Aug 16;10(5):1074–1076. doi: 10.1093/toxres/tfab089

Corrigendum to: Pathogenic characteristics and treatment in 43 cases of acute colchicine poisoning

Xiaoxia Lu 1,2,#, Yanqing Liu 1,#, Chunyan Wang 1, Jianguang Dong 1, Lili Bai 1, Chengcheng Zhang 1, Renzheng Zhang 1, Chengwen Sun 1, Zewu Qiu 1,
PMCID: PMC8557650  PMID: 34729178

In the original publication of this article, there were errors within the data of Table 1. The Table should read as follows:

Table 1.

general characteristics and clinical data of patients with acute colchicine poisoning

General characteristics Total (n = 43) Prognosis P-value
Alive (n = 32) Death (n = 11)
Age (year) 26 (22–38) 24.5 (21.25–39.25) 30.64 ± 10.73 0.666
Gender, male, n (%) 22 (51.2) 16 (50) 6 (54.5) 0.795
Time, poisoning to admission (h) 27 (20–44) 34 (19–50) 24.64 ± 8.36 0.162
Time, poisoning to treatment (h) 8 (4–18.7) 10.5 (4.38–22.5) 4 (2–19) 0.074
Initial blood concentration (ng/ml) 27.5 (10.75–50.25) 18.5 (8.25–37.5) 70.93 ± 34.31 <0.001
Ingestion dose (mg/kg) 0.5 (0.3–0.84) 0.42–0.25 1.5 (0.8–1.7) <0.001
≤0.5 mg/kg 23 (53.5) 23 (71.9) 0 (0) <0.001
0.5–0.8 mg/kg 6 (14.0) 5 (15.6) 1 (9.0) 0.972
≥0.8 mg/kg 14 (32.5) 4 (12.5) 10 (91.0) <0.001
Symptoms and syndromes, n (%)
Nausea and vomiting 41 (95.3) 30 (93.8) 11 (100) 1.000
Occurrence time (h) 4 (2–6.75) 4.5 (1.75–10.25) 4 (3–5) 0.533
Remission time (h) 52.13 ± 21.88 48 (43.5–72) 47 ± 12.96 0.186
The abdominal pain diarrhea 41 (95.3) 31 (96.9) 10 (91.0) 1.000
Occurrence time (h) 4 (2–9.25) 6.0 (3.5–16.88) 4.39 ± 2.60 0.617
Remission time (h) 72 (48–72) 72 (48–78) 72 (36–72) 0.423
Chest distress 18 (41.9) 8 (25) 10 (91.0) 0.001
Hemorrhage of digestive tract 7 (16.3) 2 (6.3) 5 (45.5) 0.010
Abdominal distension 25 (58.1) 18 (87.5) 7 (63.6) 0.941
Subcutaneous hemorrhage 15 (34.9) 6 (18.8) 9 (81.8) 0.001
Pain 17 (39.5) 12 (37.5) 5 (45.5) 0.642
Organ damage, n (%)
Heart 24 (55.8) 15 (46.9) 9 (81.8) 0.097
Coagulation 36 (83.7) 25 (78.1) 11 (100) 0.163
Liver 37 (86.0) 26 (81.3) 11 (100) 0.312
Kidney 15 (34.9) 5 (15.6) 10 (91.0) <0.001
Muscle 39 (91.0) 28 (87.5) 11 (100) 0.558
Lung (Type I respiratory failure) 15 (34.9) 4 (12.5) 11 (100) 0.000
Patient receiving treatment times/day 9 (4–14) 10.7 (6.25–16.38) 3 (2–6) <0.001

Note: Values represent the mean ± SD, numbers are n (%) or median (interquartile range).

Instead of:

Table 1.

general characteristics and clinical data of patients with acute colchicine poisoning

General characteristics Total (n = 43) Prognosis P-value
Alive (n = 32) Death (n = 11)
Age (year) 26 (22–38) 24.5 (21.25–39.25) 3.64 ± 1.73 0.666
Gender, male, n (%) 22 (51.2) 16 (50) 6 (54.5) 0.795
Time, poisoning to admission (h) 27 (20 ± 44) 34 (19 ± 50) 24.64 ± 8.36 0.162
Time, poisoning to treatment (h) 8 (4 ± 18.7) 1.5 (4.38 ± 22.5) 4 (2 ± 19) 0.074
Initial blood concentration (ng/ml) 27.5 (1.75 ± 50.25) 18.5 (8.25 ± 37.5) 7.93 ± 34.31 <0.001
Ingestion dose (mg/kg) 0.5 (0.3 ± .84) 0.4161 ± 0.2478 1.5 (0.8 ± 1.7) <0.001
≤0.5 mg/kg 23 (53.5) 23 (71.9) 0 (0) <0.001
0.5–0.8 mg/kg 6 (14.0) 5 (15.6) 1 (9.0) 0.972
≥0.8 mg/kg 14 (32.5) 4 (12.5) 10 (91.0) <0.001
Symptoms and syndromes, n (%)
Nausea and vomiting 41 (95.3) 30 (93.8) 11 (100) 1.000
Occurrence time (h) 4 (2, 6.75) 4.5 (1.75, 10.25) 4 (3, 5) 0.533
Remission time (h) 52.13 ± 21.88 48 (43.5 ± 72) 47 ± 12.96 0.186
The abdominal pain diarrhea 41 (95.3) 31 (96.9) 10 (91.0) 1.000
Occurrence time (h) 4 (2–9.25) 6.0 (3.5–16.875) 4.39 ± 2.60 0.617
Remission time (h) 72 (48–72) 72 (48–78) 72 (36–72) 0.423
Chest distress 18 (41.9) 8 (25) 10 (91.0) 0.001
Hemorrhage of digestive tract 7 (16.3) 2 (6.3) 5 (45.5) 0.010
Abdominal distension 25 (58.1) 18 (87.5) 7 (63.6) 0.941
Subcutaneous hemorrhage 15 (34.9) 6 (18.8) 9 (81.8) 0.001
Pain 17 (39.5) 12 (37.5) 5 (45.5) 0.642
Organ damage, n (%)
Heart 24 (55.8) 15 (46.9) 9 (81.8) 0.097
Coagulation 36 (83.7) 25 (78.1) 11 (100) 0.163
Liver 37 (86.0) 26 (81.3) 11 (100) 0.312
Kidney 15 (34.9) 5 (15.6) 10 (91.0) <0.001
Muscle 39 (91.0) 28 (87.5) 11 (100) 0.558
Lung (Type I respiratory failure) 15 (34.9) 4 (12.5) 11 (100) 0.000
Patient receiving treatment times/day 9 (4 ± 14) 10.7 (6.25 ± 16.38) 3 (2 ± 6) <0.001

Note: Values represent the mean ± SD, numbers are n (%) or median (interquartile range).

Table 1 has now been corrected within the article.


Articles from Toxicology Research are provided here courtesy of Oxford University Press

RESOURCES